In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMC 127660)

Published in Infect Immun on February 01, 2002

Authors

Kylie J Nolan1, David J McGee, Hazel M Mitchell, Tassia Kolesnikow, Janette M Harro, Jani O'Rourke, John E Wilson, Stephen J Danon, Nathan D Moss, Harry L T Mobley, Adrian Lee

Author Affiliations

1: School of Microbiology and Immunology, The University of New South Wales, Australia.

Articles citing this

Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72

Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol (2011) 2.03

Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J Bacteriol (2004) 1.35

The nickel-responsive regulator NikR controls activation and repression of gene transcription in Helicobacter pylori. Infect Immun (2005) 1.35

Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect Immun (2005) 1.32

The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization. Infect Immun (2006) 1.31

Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun (2004) 1.21

Association of Helicobacter pylori antioxidant activities with host colonization proficiency. Infect Immun (2003) 1.17

Host-specific induction of Escherichia coli fitness genes during human urinary tract infection. Proc Natl Acad Sci U S A (2014) 1.14

Magnesium uptake by CorA is essential for viability of the gastric pathogen Helicobacter pylori. Infect Immun (2002) 1.10

Helicobacter pylori HP1512 is a nickel-responsive NikR-regulated outer membrane protein. Infect Immun (2006) 1.04

Nickel-binding and accessory proteins facilitating Ni-enzyme maturation in Helicobacter pylori. Biometals (2007) 1.03

Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest (2012) 1.01

A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites. PLoS Pathog (2013) 0.90

Gastric infection by Helicobacter pylori. Curr Gastroenterol Rep (2009) 0.88

Iron-responsive repression of urease expression in Helicobacter hepaticus is mediated by the transcriptional regulator Fur. Infect Immun (2006) 0.84

Metal-responsive gene regulation and metal transport in Helicobacter species. Biometals (2007) 0.84

Common themes and unique proteins for the uptake and trafficking of nickel, a metal essential for the virulence of Helicobacter pylori. Front Cell Infect Microbiol (2013) 0.84

An ABC transporter and a TonB ortholog contribute to Helicobacter mustelae nickel and cobalt acquisition. Infect Immun (2010) 0.83

Nickel trafficking system responsible for urease maturation in Helicobacter pylori. World J Gastroenterol (2013) 0.82

Two stomach-originated Lactobacillus strains improve Helicobacter pylori infected murine gastritis. World J Gastroenterol (2010) 0.80

Characterization in Helicobacter pylori of a Nickel Transporter Essential for Colonization That Was Acquired during Evolution by Gastric Helicobacter Species. PLoS Pathog (2016) 0.77

Transition Metals and Virulence in Bacteria. Annu Rev Genet (2016) 0.76

Attenuation of Helicobacter pylori-induced gastric inflammation by prior cag(-) strain (AM1) infection in C57BL/6 mice. Gut Pathog (2017) 0.75

Articles cited by this

Campylobacter enteritis: a "new" disease. Br Med J (1977) 34.77

The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58

Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90

Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89

Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol (1986) 9.90

DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res (1992) 8.86

A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72

Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun (1991) 5.90

Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content. J Clin Microbiol (1985) 4.93

Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect Immun (1994) 3.42

A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect Immun (1994) 2.94

Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun (1995) 2.15

Helicobacter pylori nickel-transport gene nixA: synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol Microbiol (1995) 2.04

The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology (1998) 2.02

Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J Bacteriol (1999) 1.74

The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology (1996) 1.70

Inability of an isogenic urease-negative mutant stain of Helicobacter mustelae to colonize the ferret stomach. Infect Immun (1995) 1.63

Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect Immun (2001) 1.59

Allelic exchange mutagenesis of nixA in Helicobacter pylori results in reduced nickel transport and urease activity. Infect Immun (1996) 1.52

Hydrogen uptake hydrogenase in Helicobacter pylori. FEMS Microbiol Lett (1996) 1.46

Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol (1995) 1.42

Analysis in Neisseria meningitidis and other Neisseria species of genes homologous to the FKBP immunophilin family. Mol Microbiol (1993) 1.39

Isolation of Helicobacter pylori genes that modulate urease activity. J Bacteriol (1999) 1.28

The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology (1995) 1.24

Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology (1998) 1.23

Helicobacter pylori-associated gastritis in mice is host and strain specific. Infect Immun (1999) 1.21

Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions. Helicobacter (1999) 1.19

The life and death of Helicobacter pylori. Gut (1998) 1.14

Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol Suppl (1991) 1.12

An animal model of gastric ulcer due to bacterial gastritis in mice. Vet Pathol (1995) 1.03

Analysis of F1F0-ATPase from Helicobacter pylori. Infect Immun (1997) 0.92

[Helicobacter pylori and urease activity--comparative study between urease positive and negative mutant strains]. Nihon Rinsho (1993) 0.83

The aging stomach or the stomachs of the ages. Gut (1997) 0.79

Articles by these authors

Nature's guide for mentors. Nature (2007) 4.27

Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28

Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab (2005) 2.84

Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56

Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol (2007) 2.50

Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47

Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14

Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression. Infect Immun (2003) 2.02

Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94

Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun (2005) 1.80

Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun (2004) 1.76

Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog (2009) 1.67

Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65

Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun (2003) 1.60

Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60

Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun (2002) 1.56

Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun (2002) 1.56

Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol (2010) 1.55

Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun (2007) 1.50

The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun (2005) 1.49

Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol (2012) 1.48

Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis (2010) 1.48

Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46

Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44

Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun (2011) 1.41

Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. Int J Syst Evol Microbiol (2005) 1.40

Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun (2007) 1.39

Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol (2004) 1.37

Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect Immun (2004) 1.36

Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol (2009) 1.34

Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun (2005) 1.32

GLUT4 distribution between the plasma membrane and the intracellular compartments is maintained by an insulin-modulated bipartite dynamic mechanism. J Biol Chem (2005) 1.32

Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol (2004) 1.31

Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology (2003) 1.30

Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J Clin Microbiol (2006) 1.29

The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol (2011) 1.27

Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol (2008) 1.25

complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol (2007) 1.24

The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist (2004) 1.23

Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun (2002) 1.22

Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product designated 'KatA-associated protein', KapA (HP0874). Microbiology (2002) 1.22

Murine immune response to a chronic Staphylococcus aureus biofilm infection. Infect Immun (2011) 1.21

Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun (2004) 1.21

Transcriptome of swarming Proteus mirabilis. Infect Immun (2010) 1.19

Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A (2003) 1.16

Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect Immun (2003) 1.16

Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol (2011) 1.15

Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells. PLoS Pathog (2013) 1.14

Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol (2002) 1.14

Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun (2006) 1.14

Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus. Infect Immun (2011) 1.13

Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10

Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog (2013) 1.10

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines (2012) 1.10

Microbial dysbiosis in pediatric patients with Crohn's disease. J Clin Microbiol (2012) 1.10

Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity. J Infect Dis (2013) 1.09

The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J Immunol (2010) 1.09

Comment to: Changes of faecal microflora in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis (2012) 1.09

Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol (2008) 1.08

In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter (2006) 1.07

Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model. Antimicrob Agents Chemother (2003) 1.07

Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun (2004) 1.07

A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol Microbiol (2008) 1.07

Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio (2010) 1.07

Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun (2012) 1.06

Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect Immun (2013) 1.05

Animal models of Helicobacter pylori infection and disease. Microbes Infect (2003) 1.04

Helicobacter pylori HP1512 is a nickel-responsive NikR-regulated outer membrane protein. Infect Immun (2006) 1.04

Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae. J Bacteriol (2008) 1.04

The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. J Med Microbiol (2007) 1.04

Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio (2011) 1.04

Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli. Infect Immun (2006) 1.03

Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils. Infect Immun (2011) 1.03

The Helicobacter pylori flbA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J Med Microbiol (2002) 1.03

Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun (2004) 1.03

A Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterial. Biomaterials (2010) 1.02

A reproducible scoring system for quantification of histologic lesions of inflammatory disease in mouse gastric epithelium. Comp Med (2007) 1.02

Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infect Immun (2010) 1.01

PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli. Infect Immun (2008) 1.00

Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int (2013) 1.00

The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Am J Pathol (2005) 1.00

Characterization of Bacillus anthracis arginase: effects of pH, temperature, and cell viability on metal preference. BMC Biochem (2008) 0.99

The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol Microbiol (2011) 0.99

Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis. Infect Immun (2010) 0.99

Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis (2009) 0.98

Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect Immun (2002) 0.98

Pathogenic potential of Campylobacter ureolyticus. Infect Immun (2011) 0.98

Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice. Helicobacter (2005) 0.98

Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters. Helicobacter (2004) 0.98

Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum. BMC Microbiol (2011) 0.97